metabolic disease drugs Archives

Can Sciwind Biosciences’ ecnoglutide challenge conventional GLP-1 drugs in the expanding obesity market?

by Pallavi Madhiraju
March 8, 2026
0 Comments

China approves Sciwind Biosciences’ ecnoglutide for weight management. Discover what the biased GLP-1 mechanism could change in the obesity drug race.

Zealand Pharma advances petrelintide toward Phase 3 as obesity treatment competition intensifies

Zealand Pharma advances petrelintide toward Phase 3 after strong Phase 2 obesity trial results. Discover what this means for the evolving weight-loss drug market.